BromAc for Recurrent Peritoneal Mucinous Tumour or Pseudomyxoma Peritonei

Clinical trial NCT03976973 · UNKNOWN

Trial details

NCT number: NCT03976973
Sponsor: Mucpharm Pty Ltd
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Pseudomyxoma Peritonei Peritoneal Cancer Mucinous Adenocarcinoma Mucinous Tumor

Start date: 2022-05-01
Primary completion: 2023-11-01
Enrollment: 62

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.